Cargando…

Efficacy and safety of sodium zirconium cyclosilicate in patients with baseline serum potassium level ≥ 5.5 mmol/L: pooled analysis from two phase 3 trials

BACKGROUND: Reliable, timely-onset, oral treatments with an acceptable safety profile for patients with hyperkalemia are needed. We examined the efficacy and safety of sodium zirconium cyclosilicate (SZC; formerly ZS-9) treatment for ≤ 48 h in patients with baseline serum potassium level ≥ 5.5 mmol/...

Descripción completa

Detalles Bibliográficos
Autores principales: Amin, Alpesh N., Menoyo, Jose, Singh, Bhupinder, Kim, Christopher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889520/
https://www.ncbi.nlm.nih.gov/pubmed/31791288
http://dx.doi.org/10.1186/s12882-019-1611-8

Ejemplares similares